$226 Million is the total value of KOPP INVESTMENT ADVISORS LLC's 88 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 29.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTSS | Buy | Vitesse Semiconductor Corporation | $30,642,000 | +41.4% | 5,770,732 | +0.7% | 13.56% | +30.2% |
| IG | Buy | IGI Laboratories, Inc. | $12,409,000 | +9.6% | 1,520,775 | +18.2% | 5.49% | +0.9% |
| NEO | Buy | NeoGenomics Inc | $8,131,000 | +22.4% | 1,741,063 | +9.3% | 3.60% | +12.7% |
| SUPN | Buy | Supernus Pharmaceuticals, Inc. | $7,418,000 | +47.7% | 613,590 | +1.4% | 3.28% | +35.9% |
| STKL | Buy | SunOpta, Inc. | $6,418,000 | -1.0% | 604,334 | +10.4% | 2.84% | -8.9% |
| ATRC | Buy | AtriCure Inc. | $4,143,000 | +3.6% | 202,220 | +0.9% | 1.83% | -4.7% |
| RKUS | Buy | Ruckus Wireless Inc. | $4,113,000 | +24.8% | 319,528 | +16.6% | 1.82% | +14.9% |
| PODD | Buy | Insulet Corp. | $3,048,000 | +29.6% | 91,390 | +79.0% | 1.35% | +19.3% |
| FLDM | Buy | Fluidigm Corp. | $2,195,000 | +31.7% | 52,146 | +5.5% | 0.97% | +21.2% |
| XENT | New | Intersect ENT Inc. | $2,129,000 | – | 82,437 | +100.0% | 0.94% | – |
| QRVO | New | Qorvo | $1,943,000 | – | 24,378 | +100.0% | 0.86% | – |
| ENZ | Buy | Enzo Biochem, Inc | $1,922,000 | -33.3% | 651,415 | +0.3% | 0.85% | -38.6% |
| LGND | Buy | Ligand Pharmaceuticals Inc | $1,889,000 | +49.6% | 24,501 | +3.2% | 0.84% | +37.7% |
| EXTR | Buy | Extreme Networks, Inc. | $1,839,000 | -5.3% | 582,027 | +5.8% | 0.81% | -12.8% |
| GIMO | Buy | Gigamon Inc. | $1,603,000 | +20.8% | 75,480 | +0.8% | 0.71% | +11.1% |
| IL | Buy | IntraLinks Holdings Inc. | $1,572,000 | -12.6% | 151,995 | +0.6% | 0.70% | -19.4% |
| STRM | Buy | Streamline Health Solutions Inc. | $1,023,000 | -12.3% | 288,117 | +6.9% | 0.45% | -19.3% |
| HRL | New | Hormel Foods Corporation | $997,000 | – | 17,535 | +100.0% | 0.44% | – |
| JWN | New | Nordstrom Inc. | $979,000 | – | 12,190 | +100.0% | 0.43% | – |
| TROW | Buy | T. Rowe Price | $910,000 | -1.7% | 11,240 | +4.3% | 0.40% | -9.4% |
| AFL | Buy | Aflac Incorporated | $889,000 | +6.1% | 13,889 | +1.3% | 0.39% | -2.5% |
| VZ | Buy | Verizon Communications Inc. | $882,000 | +4.1% | 18,131 | +0.2% | 0.39% | -4.2% |
| QCOM | Buy | QUALCOMM Inc. | $870,000 | -2.7% | 12,550 | +4.4% | 0.38% | -10.5% |
| EMN | Buy | Eastman Chemical Co. | $729,000 | -8.5% | 10,531 | +0.2% | 0.32% | -15.7% |
| NOV | Buy | National Oilwell Varco Inc. | $647,000 | -4.6% | 12,945 | +25.1% | 0.29% | -12.3% |
| CVLT | Buy | CommVault Systems Inc. | $601,000 | -12.8% | 13,751 | +3.2% | 0.27% | -19.6% |
| MXL | Buy | MaxLinear, Inc.cl a | $575,000 | +17.3% | 70,719 | +6.9% | 0.25% | +7.6% |
| EGRX | New | Eagle Pharmaceuticals, Inc. | $500,000 | – | 11,925 | +100.0% | 0.22% | – |
| CEMP | Buy | Cempra, Inc | $415,000 | +56.0% | 12,085 | +6.7% | 0.18% | +43.8% |
| NXTM | Buy | NxStage Medical, Inc | $340,000 | +1.8% | 19,650 | +5.5% | 0.15% | -6.8% |
| VCSH | Buy | Vanguard Short-Term Corporateshrt trm corp bd | $321,000 | +15.1% | 4,000 | +14.3% | 0.14% | +6.0% |
| FLML | Buy | Flamel Technologies SA Spons Asponsored adr | $317,000 | +16.1% | 17,629 | +10.6% | 0.14% | +6.9% |
| VCYT | Buy | Veracyte Inc. | $268,000 | +61.4% | 36,795 | +113.8% | 0.12% | +48.8% |
| AERI | Buy | Aerie Pharmaceuticals, Inc. | $259,000 | +28.9% | 8,260 | +19.7% | 0.12% | +18.6% |
| CLDX | New | Celldex Therapeutics Inc. | $231,000 | – | 8,287 | +100.0% | 0.10% | – |
| EVDY | New | Everyday Health, Inc. | $225,000 | – | 17,460 | +100.0% | 0.10% | – |
| AAPL | New | Apple Inc. | $209,000 | – | 1,680 | +100.0% | 0.09% | – |
| TECH | New | Bio-Techne Corp. | $201,000 | – | 2,000 | +100.0% | 0.09% | – |
| NVDQ | Buy | Novadaq Technologies Inc. | $191,000 | +2.1% | 11,732 | +4.4% | 0.08% | -5.6% |
| SSH | Buy | Sunshine Heart, Inc | $63,000 | +1.6% | 14,950 | +2.3% | 0.03% | -6.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 26 | Q3 2019 | 8.2% |
| RTI Surgical Inc. | 26 | Q3 2019 | 6.0% |
| Omnicell Inc. | 26 | Q3 2019 | 4.7% |
| AtriCure Inc. | 26 | Q3 2019 | 4.6% |
| Ligand Pharmaceuticals Inc. | 26 | Q3 2019 | 4.5% |
| SPDR Trust Ser 1 | 26 | Q3 2019 | 2.3% |
| Marriott Intl. Inc. | 26 | Q3 2019 | 1.5% |
| Southwest Airls Co. | 26 | Q3 2019 | 1.3% |
| 3M Company | 26 | Q3 2019 | 1.2% |
| Aflac Incorporated | 26 | Q3 2019 | 1.1% |
View KOPP INVESTMENT ADVISORS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SUPERCONDUCTOR TECHNOLOGIES INC | August 19, 2016 | 528,963 | 16.6% |
| EMCORE CORP | April 01, 2016 | 1,248,970 | 4.8% |
| VITESSE SEMICONDUCTOR CORP | May 05, 2015 | ? | ? |
| TRANSGENOMIC INC | May 23, 2014 | 83,502 | 1.1% |
| RTI SURGICAL, INC. | January 03, 2014 | 1,984,618 | 3.5% |
| SYNERGETICS USA INC | January 03, 2014 | 877,253 | 3.5% |
| MINDSPEED TECHNOLOGIES, INC | December 13, 2013 | 2,068,416 | 4.8% |
| TRANSGENOMIC INC | November 01, 2013 | 13,744,086 | 15.6% |
| OCLARO, INC. | September 20, 2013 | 8,592,517 | 9.3% |
| SUPERCONDUCTOR TECHNOLOGIES INC | December 21, 2012 | 8,776,335 | 17.4% |
View KOPP INVESTMENT ADVISORS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR/A | 2018-08-15 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-14 |
| 13F-HR | 2018-02-14 |
| 13F-HR | 2017-11-14 |
View KOPP INVESTMENT ADVISORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.